Mirum Pharmaceuticals, Inc. (MIRM) › Operating Cash FlowMirum Pharmaceuticals, Inc. (MIRM) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$39.36M2020: -$89.08M2021: -$132.76M2022: -$120.14M2023: -$70.94M2024: $10.32M2025: $55.83M$55.83M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$55.83M+440.7%2024$10.32M+114.6%2023-$70.94M+40.9%2022-$120.14M+9.5%2021-$132.76M-49.0%2020-$89.08M-126.3%2019-$39.36M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share